- Home
- MNOV vs TONT Comparison
MNOV vs TONT Comparison
Compare MNOV & TONT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNOV | TONT |
|---|---|---|
| Founded | 2000 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.8M | 154.5M |
| IPO Year | 2004 | 2024 |
Fundamental Metrics
Financial Performance| Metric | MNOV | TONT |
|---|---|---|
| Price | $1.46 | $10.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.25 | N/A |
| AVG Volume (30 Days) | 57.5K | ★ 221.0K |
| Earning Date | 11-16-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,360,807.00 | N/A |
| Revenue This Year | $78.20 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 194.15 | N/A |
| 52 Week Low | $1.22 | $10.81 |
| 52 Week High | $3.90 | $10.97 |
Technical Indicators
Market Signals| Indicator | MNOV | TONT |
|---|---|---|
| Relative Strength Index (RSI) | 42.72 | 61.71 |
| Support Level | $1.28 | $10.89 |
| Resistance Level | $1.54 | N/A |
| Average True Range (ATR) | 0.06 | 0.01 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 51.25 | 75.00 |
Price Performance
Historical ComparisonAbout MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
About TONT Graf Global Corp. Class A ordinary shares
Graf Global Corp is a blank check company.